JP2024504822A5 - - Google Patents

Info

Publication number
JP2024504822A5
JP2024504822A5 JP2023546211A JP2023546211A JP2024504822A5 JP 2024504822 A5 JP2024504822 A5 JP 2024504822A5 JP 2023546211 A JP2023546211 A JP 2023546211A JP 2023546211 A JP2023546211 A JP 2023546211A JP 2024504822 A5 JP2024504822 A5 JP 2024504822A5
Authority
JP
Japan
Prior art keywords
approximately
csf
bleeding
subject
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023546211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/052203 external-priority patent/WO2022162218A1/en
Publication of JP2024504822A publication Critical patent/JP2024504822A/ja
Publication of JP2024504822A5 publication Critical patent/JP2024504822A5/ja
Pending legal-status Critical Current

Links

JP2023546211A 2021-02-01 2022-01-31 出血性脳卒中後の有害な二次神経学的転帰を処置または予防する方法 Pending JP2024504822A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163144043P 2021-02-01 2021-02-01
US63/144,043 2021-02-01
PCT/EP2022/052203 WO2022162218A1 (en) 2021-02-01 2022-01-31 Method of treating or preventing an adverse secondary neurological outcome following a haemorrhagic stroke

Publications (2)

Publication Number Publication Date
JP2024504822A JP2024504822A (ja) 2024-02-01
JP2024504822A5 true JP2024504822A5 (https=) 2025-03-04

Family

ID=80739092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546211A Pending JP2024504822A (ja) 2021-02-01 2022-01-31 出血性脳卒中後の有害な二次神経学的転帰を処置または予防する方法

Country Status (9)

Country Link
US (1) US20250339492A1 (https=)
EP (1) EP4284407A1 (https=)
JP (1) JP2024504822A (https=)
KR (1) KR20230142569A (https=)
CN (1) CN117136068A (https=)
AU (1) AU2022214388A1 (https=)
CA (1) CA3206884A1 (https=)
IL (1) IL304515A (https=)
WO (1) WO2022162218A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025168750A1 (en) 2024-02-09 2025-08-14 Csl Behring Ag Haptoglobin for use in treating traumatic brain injury (tbi)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137307A (en) 1973-11-15 1979-01-30 The Green Cross Corporation Process for preparing haptoglobin aqueous solution using strong anion exchanger
US4061735A (en) 1973-11-15 1977-12-06 The Green Cross Corporation Haptoglobin in aqueous solution and process for preparing the same
DE69534265T2 (de) 1994-12-12 2006-05-04 Beth Israel Deaconess Medical Center, Inc., Boston Chimäre zytokine und ihre verwendung
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
AU2003210806A1 (en) 2002-03-05 2003-09-22 Eli Lilly And Company Heterologous g-csf fusion proteins
PL2298347T3 (pl) 2003-05-06 2016-03-31 Bioverativ Therapeutics Inc Białka chimeryczne czynnika krzepnięcia do leczenia zaburzenia hemostazy
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
DK1641823T3 (da) 2003-06-12 2011-12-12 Lilly Co Eli GLP-1-analog fusionsproteiner
RU2370276C2 (ru) 2003-12-31 2009-10-20 Мерк Патент Гмбх Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ
US7670595B2 (en) 2004-06-28 2010-03-02 Merck Patent Gmbh Fc-interferon-beta fusion proteins
US20060057065A1 (en) 2004-09-11 2006-03-16 Yanming Wang Composition and method to prevent and treat brain and spinal cord injuries
EP1816201A1 (en) 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life
WO2013120939A1 (en) 2012-02-15 2013-08-22 Csl Behring Gmbh Von willebrand factor variants having improved factor viii binding affinity
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
JP6370792B2 (ja) 2012-10-03 2018-08-08 ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト タンパク質の精製方法
IL272167B2 (en) 2017-08-08 2024-02-01 Csl Behring Ag Hemopexin formulations
KR20220009984A (ko) * 2019-05-17 2022-01-25 유니베르시태트 취리히 출혈성 뇌졸중 후 2차 신경학적 이상 반응을 치료하는데 사용하기 위한 합토글로빈

Similar Documents

Publication Publication Date Title
AR074541A1 (es) Composiciones desinfectantes de plata naturales
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
JP2011500711A5 (https=)
TWD216647S (zh) 車架
JP2024504822A5 (https=)
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
JP2023508938A5 (https=)
JPWO2022071564A5 (https=)
JP2009532412A5 (https=)
JP2023552800A5 (https=)
TWD206247S (zh) 被褥乾燥機
JP2009538982A5 (https=)
RU2008131388A (ru) Покрытие предметных стекол для проведения иммуноцитохимических и гистологических исследований
DK22307C (da) Anordning ved Registre i Harmonier og Orgler, som muliggør under Spillet at tilsætte Stemmer, enkeltvis eller flere, ved Pedalbevægelser.
JP2011522018A5 (https=)
JP1750036S (ja) 電解質を用いた歯ブラシ
JP2022077837A5 (https=)
JP2022011464A5 (https=)
FR511445A (fr) Corbeilles en liteaux de bois avec cercles en chataignier, dites: "billots"
JP2005194208A (ja) 肌ピチピチ髪シットリローズマリー化粧水
JP2021021475A5 (https=)
JP1717617S (ja) 物干し台
ATE536950T1 (de) Druckfester kern mit verbessertem binder
Williams Riddles and Runes
JP2018070582A5 (https=)